Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
finasteride, Quantity: 5 mg
Strides Pharma Science Pty Ltd
Finasteride
Tablet, film coated
Excipient Ingredients: pregelatinised maize starch; lactose monohydrate; sodium starch glycollate type A; microcrystalline cellulose; magnesium stearate; docusate sodium; titanium dioxide; hypromellose; hyprolose; purified talc; iron oxide yellow; indigo carmine aluminium lake
Oral
28, 30
(S4) Prescription Only Medicine
APL-FINASTERIDE is indicated for the treatment of patients with symptomatic benign prostatic hyperplasia (BPH) with an enlarged prostate.
Visual Identification: Blue coloured, circular, biconvex, bevel edged film-coated tablets debossed with 'E' on side and '61' on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2014-04-30